BioSpace News Archive

Titan Medical Announces Pricing of Overnight Marketed Offering

Titan will issue Units at a price of US $3.40 per Unit for total gross proceeds of a minimum of US$20,000,000 and a maximum of US$25,000,000

March 6, 2019
·
5 min read
Prostate Cancer Treatment Side Effects Aren’t Side Issues When They Happen to You

According to the American Cancer Society, in 2019 an estimated 174,650 men will be diagnosed with prostate cancer.

March 6, 2019
·
2 min read
OrthoXel™ Orthopaedic Trauma Device Company Announces Early Healing in High-Risk Fractures Using Apex Tibial Nailing System Micromotion Fixation

OrthoXel is a specialist orthopaedic trauma company, using innovative engineering design to evolve truly next generation fracture fixation devices.

March 6, 2019
·
3 min read
Biotech Beach

Familial Chylomicronemia Syndrome Foundation Completes Follow-up Discussion with FDA in Effort to Find Path Forward for Investigational Treatment

Leaders in patient advocacy in FCS also met with members of Congress to highlight lack of treatment and need to bring hope to patients who currently have no options available.

March 6, 2019
·
2 min read
BioMidwest

Muscular Dystrophy Association and International Association of Fire Fighters Celebrate 65 Years of Fill the Boot Partnership

Virginia Fire Fighters Take Annual Fundraiser on the Road with March for MDA March 24

March 6, 2019
·
4 min read
Business

St. Joseph’s Hospital’s Adult Congenital Heart Program Earns Comprehensive Accreditation from the Adult Congenital Heart Association

St. Joseph’s Hospital is the first in the region and second facility in Florida to earn accreditation from the Adult Congenital Heart Association (ACHA) in recognition of its expertise in serving adults with congenital heart disease.

March 6, 2019
·
3 min read
BioMidwest

The Midwest Sees Flu Activity Gains

Walgreens Flu Index™ for Week Ending March 2, 2019

March 6, 2019
·
3 min read
IMV Inc. Closes Previously Announced Public Offering

The Corporation has granted the underwriters of the Offering a 30-day option to purchase up to an additional 735,000 common shares on the same terms and conditions.

March 6, 2019
·
4 min read
Deals

AbleTo Acquires Joyable to Further Increase Access to High-Quality Behavioral Health Care

Shared focus on clinically-sound care offers natural alignment for continued innovation

March 6, 2019
·
3 min read
BioCapital

Ayala Pharmaceuticals to Present Preclinical Data at AACR for AL101, a Pan-Notch Inhibitor Being Evaluated for Adenoid Cystic Carcinoma

Results support the clinical development of AL101 as a targeted monotherapy for people with tumors bearing Notch activated mutations

March 6, 2019
·
3 min read